Stage II BRCA1 Breast Cancer: Joy's Survivor Story
This breast cancer diagnosis at a glance
- Stage at diagnosis
- Stage II
- Biomarkers
- BRCA1 mutation
- Sex
- Female
- Treatment
- chemotherapy, surgery, hysterectomy and surveillance
- Outcome
- Cancer-Free / NED
Treatment course, step by step
- Breast lump found during self-checks
- Ultrasound, mammogram, and biopsy confirmed fast-growing Stage II breast cancer
- Chemotherapy was given first; plan was 12 weekly treatments then 4 treatments with a second drug
- Allergic reaction to the second drug led to hospitalization and a smaller-dose schedule every 3 weeks
- BRCA1 result changed surgery plan from lumpectomy to double mastectomy plus hysterectomy
- Had a 6-week break before mastectomy; port was removed during surgery
- Hysterectomy followed in June
- No evidence of disease, with oncology monitoring every 3 months then every 6 months.
What happened, in summary
Joy began checking her breasts after a friend was diagnosed with breast cancer, and that habit helped her notice a lump. A private clinic performed ultrasound, mammogram, and biopsy, and the doctor was confident it was breast cancer even before the biopsy result came back 72 hours later. Joy transferred her care to a hospital, where her team recommended chemotherapy first because the cancer was fast-growing and surgery alone might leave cancer cells behind. The plan was 16 rounds before surgery: 12 weekly treatments, then 4 treatments with a different drug. During the second drug, Joy had an allergic reaction and was hospitalized, so her oncologist changed the schedule to a smaller dose over a longer infusion every 3 weeks. Genetic testing during chemotherapy showed a BRCA1 mutation, which changed the surgical plan. Lumpectomy came off the table, and Joy moved forward with a double mastectomy and hysterectomy. She had 6 weeks between chemotherapy and surgery because her body was so worn down, then returned to work about 2 months after the November mastectomy. The hysterectomy followed in June. As of June 2026, Joy had no evidence of disease and was being monitored closely, with oncology visits moving from every 3 months to every 6 months.
Where this story comes from
This is a lay summary of an account first published by The Patient Story. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer